Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023

Rhea-AI Summary

Kiniksa Pharmaceuticals to report Q3 2023 financial results and recent portfolio execution

Positive

• Kiniksa Pharmaceuticals will host a conference call and webcast to report its third quarter 2023 financial results and recent portfolio execution. The live webcast will be accessible through the company's website. A replay of the event will also be available on the website.

Negative

• None.

HAMILTON, Bermuda, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 31, 2023 at 8:30 a.m. Eastern Time to report its third quarter 2023 financial results and recent portfolio execution.

A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets, ARCALYST, KPL-404, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.

ARCALYST^® is a registered trademark of Regeneron Pharmaceuticals, Inc.

Every Second Counts! ^®

Kiniksa Investor and Media Contact
Rachel Frank
(339) 970-9437
rfrank@kiniksa.com

FAQ

When will Kiniksa Pharmaceuticals report its Q3 2023 financial results?

Kiniksa Pharmaceuticals will report its Q3 2023 financial results on Tuesday, October 31, 2023.

How can I access the conference call and webcast?

The conference call and webcast can be accessed through the Investors & Media section of Kiniksa Pharmaceuticals' website.

Will there be a replay of the event?

Yes, a replay of the event will be available on Kiniksa Pharmaceuticals' website within approximately 48 hours after the event.